Elucidating the acute effects of medically prescribed oral and vaporised delta‐9‐tetrahydrocannabinol on cognitive functions important for driving
Drug and Alcohol Review · 2025
DOI: 10.1111/dar.14060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Kayla B Stefanidis und 5 weiteren Autor:innen. Beteiligte Einrichtung: MAIC/UniSC Road Safety Research Collaboration, University of the Sunshine Coast, Sippy Downs, Australia. Hauptthemen laut MEDLINE: Dronabinol, Cognition, Automobile Driving, Medical Marijuana. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This research was funded by the Motor Accident Insurance Commission. The funders did not have any role in the study design, data collection and analysis, decis….
Abstract (Originalsprache)
Introduction
This program of research investigated the acute effects of orally ingested (Study 1) and vaporised (Study 2) cannabis containing delta‐9‐tetrahydrocannabinol (THC) on cognitive functions relevant for driving in two samples of medicinal cannabis patients (Study 1 N = 41 oral users; Study 2 N = 37 flower users).
Method
Participants completed counterbalanced baseline (no cannabis) and cannabis consumption (post‐cannabis) appointments scheduled approximately 1 week apart. During each session, participants were administered a cognitive battery assessing information processing speed, sustained and divided attention, inhibitory control and mental flexibility. In the post‐cannabis condition, the battery was completed 90 min after consuming one dose of cannabis oil (Study 1) or 15 min after vaporising one dose of cannabis flower (Study 2).
Results
In both samples, acute cannabis oil and flower administration did not induce a change in information processing speed, divided and sustained attention, or inhibitory control performance (after excluding participants with a positive drug indication at the start of either session), highlighting the moderating role of tolerance. However, significant reductions in TMT B performance were observed. Further, TMT ratio was significantly reduced post consumption of cannabis oil. Discussion and Conclusions TMT B may be sensitive to acute cannabis consumption in medicinal cannabis patients. However, further research is needed to determine the nature and duration of these effects, and whether such effects vary depending on the population studied (e.g., regular vs. new users).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MAIC/UniSC Road Safety Research Collaboration, University of the Sunshine Coast, Sippy Downs, Australia.
- Minerals Industry Safety and Health Centre, Sustainable Minerals Institute, The University of Queensland, Brisbane, Australia.
- School of Psychology, The University of Queensland, Brisbane, Australia.
- Discipline of Psychology, School of Health, University of the Sunshine Coast, Sippy Downs, Australia.
ORCID-Profile: Kayla B Stefanidis, Taren Mieran
Förderung
- This research was funded by the Motor Accident Insurance Commission. The funders did not have any role in the study design, data collection and analysis, decis…
Zitieren
APA
Stefanidis, K. B., Schiemer, C., Mieran, T., Hill, A., Horswill, M. S., & Summers, M. J. (2025). Elucidating the acute effects of medically prescribed oral and vaporised delta‐9‐tetrahydrocannabinol on cognitive functions important for driving. Drug and Alcohol Review. https://doi.org/10.1111/dar.14060
Vancouver
Stefanidis KB, Schiemer C, Mieran T, Hill A, Horswill MS, Summers MJ. Elucidating the acute effects of medically prescribed oral and vaporised delta‐9‐tetrahydrocannabinol on cognitive functions important for driving. Drug and Alcohol Review. 2025. doi:10.1111/dar.14060
BibTeX
@article{Stefanidis2025,
author = {Stefanidis, Kayla B and Schiemer, Carla and Mieran, Taren and Hill, Andrew and Horswill, Mark S and Summers, Mathew J},
title = {Elucidating the acute effects of medically prescribed oral and vaporised delta‐9‐tetrahydrocannabinol on cognitive functions important for driving},
journal = {Drug and Alcohol Review},
year = {2025},
doi = {10.1111/dar.14060}
}
EUVIMED